Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05626270 · ClinicalTrials.gov registry record · NA
Human Factors Testing for OTC Use of the Erchonia® LunulaLaser
A NA study, sponsored by Erchonia Corporation.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT05626270 is a NA study that has completed, run by Erchonia Corporation. The registered enrollment target is 15 participants.
The verdict
NCT05626270, a NA study, has completed, sponsored by Erchonia Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
Human factors validation testing to assess the intended user's ability to correctly, safely, and effectively set-up, activate and operate the LunulaLaser™ OTC, to administer a treatment to a suitably qualified client, and to understand the information contained in the Erchonia LunulaLaser™ OTC Installation and Proper Use Reference Guide and box labeling.
Interventions
- DEVICE LunulaLaser OTC
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2021-06-04 |
| Est. Completion | 2022-12-23 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05626270
The ClinicalTrials.gov registry entry for NCT05626270 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Erchonia Corporation, which has 34 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which LunulaLaser OTC is the first listed.
NCT05626270 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05626270 about?
NCT05626270 is a clinical study titled "Human Factors Testing for OTC Use of the Erchonia® LunulaLaser". Human factors validation testing to assess the intended user's ability to correctly, safely, and effectively set-up, activate and operate the LunulaLaser™ OTC, to administer a treatment to a suitably qualified client, and to understand the information contained in the Erchonia LunulaLaser™ OTC Insta...
What is the current status of trial NCT05626270?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2021-06-04. Estimated completion is 2022-12-23.
What interventions are being tested in trial NCT05626270?
The interventions under investigation include: LunulaLaser OTC (DEVICE).
Who is sponsoring clinical trial NCT05626270?
This trial is sponsored by Erchonia Corporation, which has 34 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.